These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11248033)

  • 1. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
    Podust LM; Poulos TL; Waterman MR
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3068-73. PubMed ID: 11248033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.
    Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J
    J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate recognition sites in 14alpha-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51.
    Podust LM; Stojan J; Poulos TL; Waterman MR
    J Inorg Biochem; 2001 Dec; 87(4):227-35. PubMed ID: 11744060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity.
    Lamb DC; Kelly DE; White TC; Kelly SL
    Antimicrob Agents Chemother; 2000 Jan; 44(1):63-7. PubMed ID: 10602724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions.
    Sheng C; Zhang W; Zhang M; Song Y; Ji H; Zhu J; Yao J; Yu J; Yang S; Zhou Y; Zhu J; Lu J
    J Biomol Struct Dyn; 2004 Aug; 22(1):91-9. PubMed ID: 15214809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole.
    Rupp B; Raub S; Marian C; Höltje HD
    J Comput Aided Mol Des; 2005 Mar; 19(3):149-63. PubMed ID: 16059669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
    Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology.
    Bellamine A; Lepesheva GI; Waterman MR
    J Lipid Res; 2004 Nov; 45(11):2000-7. PubMed ID: 15314102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analyses of
    Hargrove TY; Friggeri L; Wawrzak Z; Qi A; Hoekstra WJ; Schotzinger RJ; York JD; Guengerich FP; Lepesheva GI
    J Biol Chem; 2017 Apr; 292(16):6728-6743. PubMed ID: 28258218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B' helix defines substrate preferences of sterol 14alpha-demethylase.
    Lepesheva GI; Zaitseva NG; Nes WD; Zhou W; Arase M; Liu J; Hill GC; Waterman MR
    J Biol Chem; 2006 Feb; 281(6):3577-85. PubMed ID: 16321980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds.
    Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y
    J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis.
    Matsuura K; Yoshioka S; Tosha T; Hori H; Ishimori K; Kitagawa T; Morishima I; Kagawa N; Waterman MR
    J Biol Chem; 2005 Mar; 280(10):9088-96. PubMed ID: 15611056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis.
    Bellamine A; Mangla AT; Nes WD; Waterman MR
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8937-42. PubMed ID: 10430874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folding requirements are different between sterol 14alpha-demethylase (CYP51) from Mycobacterium tuberculosis and human or fungal orthologs.
    Lepesheva GI; Podust LM; Bellamine A; Waterman MR
    J Biol Chem; 2001 Jul; 276(30):28413-20. PubMed ID: 11373285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem.
    Kelly SL; Lamb DC; Kelly DE
    FEMS Microbiol Lett; 1999 Nov; 180(2):171-5. PubMed ID: 10556708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents.
    Lamb DC; Kelly DE; Waterman MR; Stromstedt M; Rozman D; Kelly SL
    Yeast; 1999 Jun; 15(9):755-63. PubMed ID: 10398344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.
    Fukuoka T; Johnston DA; Winslow CA; de Groot MJ; Burt C; Hitchcock CA; Filler SG
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1213-9. PubMed ID: 12654649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diversity of sterol 14alpha-demethylase substrates in plants, fungi and humans.
    Lamb DC; Kelly DE; Kelly SL
    FEBS Lett; 1998 Mar; 425(2):263-5. PubMed ID: 9559662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.